Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In the REDEFINE 1 trial, published in the New England Journal of Medicine, participants receiving the combination achieved 20.4% mean body weight reduction at 68 weeks
Unfortunately, its concentration drops as we age
A 12-week clinical trial showed subjects taking AOD-9604 (1 mg/d) lost an average of 2.6 kg, compared to 0.8 kg in the placebo group.
Dihexa demonstrates potent anti-neuroinflammatory effects critical for neuroprotection
Synergy with Other Interventions The appetite-neutral nature of AOD-9604 makes it compatible with various other weight management strategies without creating conflicting signals
30074-7/asset/5367a357-b6ae-4d9a-9e38-d2422800e400/main.assets/gr3_lrg.jpg)
30194-9/asset/e2a34f3b-6f8a-425f-9e34-2cf394cbb616/main.assets/gr4_lrg.jpg)
00459-9/asset/e4c0896a-ac7a-460c-8a8f-e5b97bab8187/main.assets/gr2_lrg.jpg)